|
AGIO
|
Agios Pharmaceuticals, Inc.
|
1.59%
|
US
|
NASDAQ
|
|
PRVB
|
Provention Bio, Inc.
|
1.58%
|
US
|
NASDAQ
|
|
BLUE
|
bluebird bio, Inc.
|
1.58%
|
US
|
NASDAQ
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
1.57%
|
US
|
NASDAQ
|
|
INSM
|
Insmed, Inc.
|
1.56%
|
US
|
NASDAQ
|
|
IMCR
|
Immunocore Holdings plc
|
1.56%
|
US
|
NASDAQ
|
|
CTIC
|
Cell Therapeutics, Inc.
|
1.55%
|
US
|
NASDAQ
|
|
HRMY
|
Harmony Biosciences Holdings, Inc.
|
1.54%
|
US
|
NASDAQ
|
|
NKTR
|
Nektar Therapeutics
|
1.49%
|
US
|
NASDAQ
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
1.49%
|
US
|
NASDAQ
|
|
MRNA
|
Moderna, Inc.
|
1.45%
|
US
|
NASDAQ
|
|
AXSM
|
Axsome Therapeutics, Inc.
|
1.44%
|
US
|
NASDAQ
|
|
IMGN
|
ImmunoGen, Inc.
|
1.43%
|
US
|
NASDAQ
|
|
TSVT
|
2seventy bio, Inc.
|
1.37%
|
US
|
NASDAQ
|
|
BNTX
|
BioNTech SE
|
1.36%
|
US
|
NASDAQ
|
|
BBIO
|
BridgeBio Pharma, Inc.
|
1.30%
|
US
|
NASDAQ
|